Merck & Co., Inc.

Pharmaceutical Preparations·RAHWAY, NJ·FY end 12/31·CIK 310158

Named Executive Officers

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Robert M. DavisChairman, Chief Executive Officer and President	$1.6M	$12.1M	$3.4M	$2.3M	$1.3M	$20.8M
Caroline LitchfieldExecutive Vice President and Chief Financial Officer	$1.2M	$1.0M	$1.1M	$4.1M	$7.6M	—
Dean LiM.D., Ph.D. Executive Vice President and President, Merck Research Laboratories	$1.5M	$1.2M	$1.4M	$4.7M	$9.1M	—
Jennifer ZacharyExecutive Vice President and General Counsel	$1.1M	$750.0K	$995.7K	$2.9M	$6.0M	—
Sanat ChattopadhyayExecutive Vice President and President, Merck Manufacturing Division	$982.2K	$660.0K	$920.7K	$2.7M	$5.6M	—

Robert M. Davis · FY 2025

Stock awards$12.1M58%

Performance bonus$2.3M11%

Salary$1.6M8%

Other$4.7M23%

TSR % vs. CEO comp actually paid · 5 fiscal years · Item 402(v) disclosure

TSR

CEO comp

FY21

+2%

$14M

FY22

+52%

$52M

FY23

+54%

$27M

FY24

+44%

$15M

FY25

+58%

$16M

Need at least two fiscal years of proxy data to draw the trend line. The ingestion worker will populate prior-year proxies as it processes them.